Journal of Exotic Pet Medicine
Volume 18, Issue 3 , Pages 229-231 , July 2009

Praziquantel

  • Megan Watson, BS

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Megan Watson, BS, University of Illinois, College of Veterinary Medicine, 1008 W. Hazelwood Dr, Urbana, IL 61802

References 

  1. Pearson RD, Guerrant RL. Praziquantel: a major advance in anthelminthic therapy. Ann Intern Med. 1983;99:195–198
  2. Cioli D, Pica-Mattocia L. Praziquantel. Parasitol Res. 2003;90:S3–S9
  3. Castro N, Medina R, Sotelo J, et al. Bioavailability of praziquantel increases with concomitant administration of food. Antimicrob Agents Chemotherap. 2000;44:2903–2904
  4. Mandour MEM, Turabi HE, Homeida MMA, et al. Pharmacokinetics of praziquantel in healthy volunteers and patients with schistosomiasis. Trans R Soc Trop Med Hyg. 1990;84:389–393
  5. Giorgi M, Meucci V, Vaccaro E, et al. Effects of liquid and freeze-dried grapefruit juice on the pharmacokinetics of praziquantel and its metabolite 4[prime]-hydroxy praziquantel in beagle dogs. Pharmacol Res. 2003;47:87–92
  6. Leopold G, Ungethum W, Groll E, et al. Clinical pharmacology in normal volunteers of praziquantel, a new drug against schistosomes and cestodes. Eur J Clin Pharmacol. 1978;14:281–291
  7. King CH, Mahmoud AAF. Drugs five years later: praziquantel. Ann Intern Med. 1989;110:290–296
  8. Dinora G-E, Julio R, Nelly C, et al. In vitro characterization of some biopharmaceutical properties of praziquantel. Int J Pharm. 2005;295:93–99
  9. Dayan AD. Albendazole, mebendazole and praziquantel (Review of non-clinical toxicity and pharmacokinetics). Acta Trop. 2003;86:141–159
  10. Plumb DC. Praziquantel. In:  Plumb DC editors. Veterinary Drug Handbook. (ed 4). Ames, IA: Blackwell Publishing; 2002;p. 680–682
  11. Liang Y-S, Coles GC, Doenhoff MJ, et al. In vitro responses of praziquantel-resistant and susceptible Schistosoma mansoni to praziquantel. Int J Parasitol. 2001;31:1227–1235
  12. Bygott JM, Chiodini PL. Praziquantel: neglected drug? (Ineffective treatment? Or therapeutic choice in cystic hydatid disease? Acta Trop). 2009;doi:10.1016/j.actatropica. 2009.04.006
  13. Sinha S, Sharma BS. Neurocysticercosis: a review of current status and management. J Clin Neurosci. 2009;16:867–876
  14. Harnett W, Kusel JR. Increased exposure of parasite antigens at the surface of adult male Schistosoma mansoni exposed to praziquantel in vitro. Parasitol. 1986;93(Pt 2):401–405
  15. Greenberg RM. Are Ca2+ channel targets of praziquantel action?. Int J Parasitol. 2005;35:1–9
  16. McTigue MA, DeWight RW, Tainer JA. Crystal structure of a schistosomal drug and vaccine target: glutathione S-transferase from Schistosoma japonica and its complex with the leading antischistosomal drug praziquantel. J Mol Biol. 1995;246:21–27
  17. Bogan J, Armour J. Anthelmintics for ruminants. Int J Parasitol. 1987;17:483–491
  18. Rehbein S, Visser M, Yoon S, et al. Efficacy of a combination ivermectin/praziquantel paste against nematodes, cestodes and bots in naturally infected ponies. Vet Rec. 2007;161:722–724
  19. Slocombe JOD, Heine J, Barutzki D, et al. Clinical trials of efficacy of praziquantel horse paste 9% against tapeworms and its safety in horses. Vet Parasitol. 2007;144:366–370
  20. Heath DD, Lawrence SB. The effect of mebendazole and praziquantel on the cysts of Echincoccus granulosus, Taenia hydatigena and T. ovis in sheep. NZ Vet J. 1978;26:11–15
  21. Montoya A, Dado D, Mateo M, et al. Efficacy of Drontal® Flavour Plus (50 mg praziquantel, 144 mg pyrantel embonate, 150 mg febantel per tablet) against Giardia sp in naturally infected dogs. Parasitol Res. 2008;103:1141–1144
  22. Schuster RK, Heidrich J, Pauly A, et al. Liver flukes in dogs and treatment with praziquantel. Vet Parasitol 150. 2007;362–365
  23. Mehlmorn H, Schmahl G, Frese M, et al. Effects of a combination of emodepside and praziquantel on parasites of reptiles and rodents. Parasitol Res. 2005;97:S64–S69
  24. Jacobsen ER, Harman GR, Maxwell LK, et al. Plasma concentrations of praziquantel after oral administration of single and multiple doses in loggerhead sea turtles (Caretta caretta). Am J Vet Res 64(3). 2003;304–309
  25. Schroeder J. Praziquantel in turtles. Aust Vet J. 1998;76:107
  26. Adnyana W, Ladds PW, Blair D. Efficacy of praziquantel in the treatment of green sea turtles with spontaneous infection of cardiovascular flukes. Aust Vet J. 1997;75:405–407
  27. Rajendran M, Nadakal AM. The efficacy of praziquantel (Droncit®) against Raillietina tetracona (Molin, 1858) in domestic fowl. Vet Parasitol. 1988;26:253–260
  28. Reimink RL, DeGoede JA, Blankespoor HD. Efficacy of praziquantel in natural populations of mallards infected with avian schistosomes. J Parasitol. 1995;81:1027–1029
  29. Thorney DA. The effects of trichlorfon, praziquantel and copper sulphate on various stages of the monogenean Benedeniella posterocolpa, a skin parasite of the cownose ray, Rhinoptera bonasus (Mitchill). J Fish Dis. 1990;13:385–389
  30. Gai JJ, Marks SL. Salmon poisoning disease in two Malayan sun bears. J Am Vet Med Assoc. 2008;232:586–588

PII: S1557-5063(09)00060-3

doi: 10.1053/j.jepm.2009.06.005

Journal of Exotic Pet Medicine
Volume 18, Issue 3 , Pages 229-231 , July 2009

Article Tools